Get started
Author

Bedor A. Al-Omari

Observed names: Al Omari, Bedor, Bedor A Al-Omari, Bedor A. AlOmari, Bedor A. Alomari, Bedor Abdullah Abdulrahman Alomari, Bedor Abdullahal Omari, Bedor Al Omari, Bedor AlOmari, Bedor Alomari
Observed institutions: Princess Nourah bint Abdulrahman University, Riyadh Armed Forces Hospital, Alfaisal University, King Abdulaziz University, King Saud bin Abdulaziz University for Health Sciences, King Saud Medical City, King Saud University, Saudi Commission for Health Specialties, King Abdullah International Medical Research Center, King Abdul Aziz University Hospital, Dar Al Uloom University, Imam Abdulrahman Bin Faisal University
ORCID: 0000-0002-8441-4870
Observed ORCID: 0000-0002-8441-4870
OpenAlex ID: A5027134308
Clinical pharmacy definition, required education, training and practice in Saudi Arabia: A position statement by the Saudi society of clinical pharmacy
2021 · Ghazwa B. Korayem, Hisham A. Badreldin, et al. · Saudi Pharmaceutical Journal · 36
PDF
Saudi Arabia consensus guidance for the diagnosis and management of adults with inflammatory bowel disease
2022 · Mahmoud H. Mosli, Hajer Y. Almudaiheem, et al. · Saudi Journal of Gastroenterology · 27
Prevalence of complementary and alternative medicine use among rheumatoid arthritis patients in Saudi Arabia
2019 · Aseel M. Almuhareb, Tariq M. Alhawassi, et al. · Saudi Pharmaceutical Journal · 26
PDF
Pharmacists roles and responsibilities during epidemics and pandemics in Saudi Arabia: An opinion paper from the Saudi Society of clinical pharmacy
2020 · Hisham A. Badreldin, Shahad Raslan, et al. · Saudi Pharmaceutical Journal · 21
PDF
National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021)
2022 · Mohammad I. Fatani, Afaf A. Al Sheikh, et al. · Dermatology and Therapy · 12
PDF
Saudi consensus statement on biologic treatment of chronic plaque psoriasis (2020)
2021 · Mohammad Ibrahim Ahmad Fatani, Issam Ribhi Ahmad Hamadah, et al. · Journal of Dermatological Treatment · 12
The Saudi consensus recommendations for the management of psoriatic arthritis (2023)
2024 · Ibrahim Abdulrazag Al-Homood, Nayef Al Ghanim, et al. · Clinical Rheumatology · 9
PDF
Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia
2024 · Hana Al-Abdulkarim, Yuvraj Sharma, et al. · Journal of Medical Economics · 7
PDF
Clinical Pharmacist Core Competencies in Saudi Arabia: A Position Paper by the Saudi Society of Clinical Pharmacy
2022 · Hisham A Badreldin, Ahmed Aldemerdash, et al. · Saudi Journal of Clinical Pharmacy · 7
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents
2024 · Omar I. Saadah, Turki AlAmeel, et al. · Saudi Journal of Gastroenterology · 6
Relationship between different anti-rheumatic drug therapies and complementary and alternative medicine in patients with rheumatoid arthritis: an interview based cross-sectional study
2021 · Haya M. Almalag, Aseel M. Almuhareb, et al. · Saudi Pharmaceutical Journal · 5
PDF
Saudi clinical practice guidelines for the treatment and prevention of migraine headache
2025 · Faisal A. Al-Suwaidan, Hajer Y. Almudaiheem, et al. · Neurosciences · 4
PDF
Saudi National Clinical Practice Guidelines for Management of Adult Systemic Lupus Erythematosus
2024 · Ahmed H. Al-Jedai, Hajer Y. Almudaiheem, et al. · Current Rheumatology Reviews · 4
Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy
2023 · Nahla A. Azzam, Abdulelah Almutairdi, et al. · Saudi Journal of Gastroenterology · 4
Saudi Clinical Practice Guidelines for management of diabetic kidney disease in adults
2025 · Khalid I. Almatham, Hajer Y. Almudaiheem, et al. · Saudi Medical Journal · 3
PDF
Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Family Planning within the Management of MS
2023 · Mona M. Al-Khawajah, Rayan G. Al-Barakati, et al. · Clinical and Translational Neuroscience · 3
PDF
Saudi Clinical Practice Guidelines for Management of Axial Spondyloarthritis Disease
2025 · Hanan Al Rayes, Nayef Al Ghanim, et al. · Rheumatology and Therapy · 2
PDF
Review on recommendations on the use of biologic therapy for the management of moderate-severe psoriasis in Saudi Arabia: an expert opinion
2025 · Mohammed Fatani, Abdullah Aldugaither, et al. · Expert Opinion on Biological Therapy · 2
Saudi Consensus Recommendations on the Management of Multiple Sclerosis: Symptom Management and Vaccination
2023 · Ibtisam A. Al Thubaiti, Mona M. AlKhawajah, et al. · Clinical and Translational Neuroscience · 2
PDF
Practical guidelines on medical management of adults with moderate-to-severe inflammatory bowel disease
2025 · Mahmoud H. Mosli, Badr Al-Bawardy, et al. · Saudi Journal of Gastroenterology · 1
Transforming rheumatoid arthritis care: dynamic budget impact models with ACR to DAS28 mapping for anti-TNFs, JAK inhibitors, and interleukins
2025 · Ahmed Al-Jedai, Hajer Al-Mudaiheem, et al. · Clinical Rheumatology · 1
Enhancing Adverse Drug Reaction Reporting in Tertiary Hospital in Saudi Arabia: An Evaluation of Methods and Strategies
2024 · Hamdah Hameed Al Enazi, Yasmin Abdul-Jabbar Barnawi, et al. · Saudi Journal of Medical and Pharmaceutical Sciences · 1
PDF
Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update
2026 · Mohammed Ibrahim Fatani, Yousef Binamer, et al. · Journal of Dermatological Treatment
PDF
Practical Saudi Guidelines on management of moderate-to-severe psoriasis: 2026 update
2026 · Mohammed Ibrahim Fatani, Yousef Binamer, et al. · Figshare
Assessing the Level of Awareness for the Optimal Use of Medication Among Saudi Community
2019 · Bedor A. Al-Omari, Khalid Alyahya · Global Journal of Medical Therapeutics
Works count: 26
Citation count: 195
H-index: 7
I10-index: 6
Year
Topic
Type